Tilray Brands Inc header image

Tilray Brands Inc

TLRY

Equity

ISIN null / Valor 42386407

NASDAQ (2026-07-02)
USD 4.62+4.29%

Tilray Brands Inc
UMushroom community rating:

star star star star star
2.50 2 votes No rating yet
NegativeNeutralPositive

About company

Tilray Brands Inc. is a global pioneer in the research, cultivation, production, and distribution of cannabis and cannabinoids. The company prides itself on a scientific approach to product development, emphasizing active ingredients, standardized preparations, and consistent, measured dosing. Tilray's product portfolio is rigorously tested for potency and purity, ensuring high-quality offerings across various categories, including medicinal and recreational cannabis. Under the leadership of CEO Irwin D. Simon, who has over 30 years of experience in building consumer packaged goods companies, Tilray has positioned itself as a leader in the global cannabis market. Simon's previous success in transforming Aphria Inc. into a profitable entity and his foundational role at The Hain Celestial Group highlight his capability to steer Tilray towards significant growth and market share. The company's operational excellence spans from cultivation to shipping, with a focus on precision, professionalism, and care at every stage of the process, aiming to deliver unparalleled products to its patients and consumers.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results ():

Summarized from source with an LLMView Source

Key figures

-4.78%1Y
-70.4%3Y
-97.3%5Y

Performance

119%1Y
95.7%3Y
90.4%5Y

Volatility

Market cap

538 M

Market cap (USD)

Daily traded volume (Shares)

5,594,016

Daily traded volume (Shares)

1 day high/low

1.415 / 1.33

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

2.50

2 votes
Performance:
starstarstarstarstar
2.00
Innovation:
starstarstarstarstar
3.00
Society:
starstarstarstarstar
2.50
Nature:
starstarstarstarstar
2.50
Robin Roten
Switzerland, 04 Dec 2022
star star star star star
Tej Ram Kumpakha
Switzerland, 25 Mar 2022
star star star star star
Though the company is not successful yet to achieve the positive net profit; the share price is likely to increase mainly due the House Rules Committee voting on legalizing Cannabis.

EQUITIES OF THE SAME SECTOR

Pacira BioSciences Inc
Pacira BioSciences Inc Pacira BioSciences Inc Valor: 12338490
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.44%USD 25.39
Ironwood Pharmaceuticals Inc
Ironwood Pharmaceuticals Inc Ironwood Pharmaceuticals Inc Valor: 10773079
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
5.10%USD 4.33
Abbott India Limited
Abbott India Limited Abbott India Limited Valor: 561999
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.50%INR 25,850.45
Arvinas Inc
Arvinas Inc Arvinas Inc Valor: 43526042
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
2.32%USD 8.39
Rhythm Pharmaceuticals Inc
Rhythm Pharmaceuticals Inc Rhythm Pharmaceuticals Inc Valor: 25337263
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
3.41%USD 114.17
Catalyst Pharmaceuticals Inc
Catalyst Pharmaceuticals Inc Catalyst Pharmaceuticals Inc Valor: 2649177
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.03%USD 31.45
Astrana Health Inc
Astrana Health Inc Astrana Health Inc Valor: 28041888
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.28%USD 49.17
Amphastar Pharmaceuticals Inc
Amphastar Pharmaceuticals Inc Amphastar Pharmaceuticals Inc Valor: 24511852
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-2.29%USD 19.64
Schrodinger Inc
Schrodinger Inc Schrodinger Inc Valor: 51947209
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
2.99%USD 16.88
BridgeBio Pharma Inc
BridgeBio Pharma Inc BridgeBio Pharma Inc Valor: 48204826
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
3.58%USD 77.19